16511-38-9

Basic information

• Product Name: 1H-[1]-BENZAZEPHE-2,5(3H, 4H)-DIONE
• Synonyms: 1H-[1]-BENZAZEPHE-2,5(3H, 4H)-DIONE;3,4-Dihydro-1H-benzo[b]azepine-2,5-dione;3,4-Dihydro-1H-1-benzazepine-2,5-dione;1H-[1]-Benzazepin-2,5(3H,4H)-dione;2,3,4,5-Tetrahydro-1H-1-benzazepine-2,5-dione;NSC 641163;2,3,4,5-tetrahydro-1H-Benzazepine-2,5-dione;ethyl 5-hydroxy-2-oxo-1,3-dihydro-1-benzazepine-4-carboxylate
• CAS NO: 16511-38-9
• Molecular Formula: C₁₀H₉NO₂
• Molecular Weight: 175.18396
• Product Categories: Aromatics;Heterocycles;Intermediates
• Mol File: 16511-38-9.mol
• Article Data: 23

Chemical Properties

• Melting Point: 177-179°C
• Boiling Point: 393.5 °C at 760 mmHg
• Flash Point: 184.9 °C
• Appearance: White Solid
• Density: 1.224 g/cm³
• Vapor Pressure: 2.12E-06mmHg at 25°C
• Refractive Index: 1.565
• Storage Temp.: Refrigerator
• Solubility: Chloroform
• PKA: 13.88±0.20(Predicted)
• CAS DataBase Reference: 1H-[1]-BENZAZEPHE-2,5(3H, 4H)-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-[1]-BENZAZEPHE-2,5(3H, 4H)-DIONE(16511-38-9)
• EPA Substance Registry System: 1H-[1]-BENZAZEPHE-2,5(3H, 4H)-DIONE(16511-38-9)

Safety Data

• Hazardous Substances Data: 16511-38-9(Hazardous Substances Data)

Usage

Chemical Properties

White Solid

Uses

Intermediate in the synthesis of protein kinase inhibitors

InChI:InChI=1/C10H9NO2/c12-9-5-6-10(13)11-8-4-2-1-3-7(8)9/h1-4H,5-6H2,(H,11,13)

Upstream product

• 108993-98-2 2,3,-Dihydro-5-hydroxy-2-oxo-1H-1-benzazepin-4-carbonsaeureethylester 
• 130-15-4 [1,4]naphthoquinone 
• 10315-38-5 2,5-Dihydro-2,5-dioxobenzazepine 
• 4424-80-0 2,3,4,5-tetrahydro-1H-1-benzo[b]azepin-2-one 
• 120572-38-5 4-[(2-ethoxycarbonylphenyl)amino]-4-oxobutanoic acid 
• 134-20-3 2-carbomethoxyaniline 
• 59868-50-7 4-[2-(methoxycarbonyl)anilino]-4-oxobutanoic acid methyl ester 
• 59868-53-0 2,5-dioxo-2,3,4,5-tetrahydro-1H-benz[b]azepine-4-carboxylic acid methyl ester 
• 2942-58-7 diethyl cyanophosphonate 
• 253264-94-7 ethyl 4-(2-aminophenyl)-4-oxobutanoate 
• 87-25-2 2-ethoxycarbonylaniline 
• 120572-43-2 diethyl ester of succinoylanthranilic acid 

Downstream Products

• 1026249-57-9 4-[3-(4-Chloro-phenyl)-3-oxo-1-phenyl-propyl]-3,4-dihydro-1H-benzo[b]azepine-2,5-dione 
• 1027245-31-3 4-[1-(4-Bromo-phenyl)-3-oxo-3-phenyl-propyl]-3,4-dihydro-1H-benzo[b]azepine-2,5-dione 
• 1026166-45-9 4-(3-Naphthalen-2-yl-3-oxo-1-phenyl-propyl)-3,4-dihydro-1H-benzo[b]azepine-2,5-dione 
• 1027411-02-4 4-[1-(4-Methoxy-phenyl)-3-oxo-3-phenyl-propyl]-3,4-dihydro-1H-benzo[b]azepine-2,5-dione 
• 936566-24-4 C₂₆H₂₂ClNO₄ 
• 936566-16-4 C₂₆H₂₂ClNO₄ 
• 169614-68-0 2,4-Diphenyl-5,7-dihydro-1,7-diaza-dibenzo[a,c]cyclohepten-6-one 

Relevant articles and documents

Fast and calibration free determination of first order reaction kinetics in API synthesis using in-situ ATR-FTIR

In early stages of drug development only sparse amounts of the key substances are available, which is problematic for the determination of important process data like reaction kinetics. Therefore, it is important to perform experiments as economically as

Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABAA α5 inverse agonist series

Through iterative design cycles we have discovered a number of novel new classes where the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine was deemed the most promising GABAA α5 inverse agonist class with potential for cognitive enhanc

Tumor-inhibiting anellated azepinone derivatives

This invention relates to anellated azepinone derivatives, a method of their production, metal complexes of the anellated azepinone derivatives as well as their use in the treatment of tumor diseases.